Table 1.
Patient’s characteristics
| Patient | Age | Weight (BMI) | Endometriosis stages∗ |
Comorbidities | Ongoing hormonal therapy and menstrual cycle | Menstrual cycle phase | Other medications |
|---|---|---|---|---|---|---|---|
| 1 | 36 | 56 Kg (18.7) | III | / | Estroprogestinic therapy | / | / |
| 2 | 46 | 78 Kg (25.5) | IV | / | Spontaneous cycle | Not declared in preoperative evaluation | / |
| 3 | 32 | 65 Kg (28) | IV | Left hydronephrosis (grade II) | Progestinic therapy | / | / |
| 4 | 41 | 67 Kg (23.2) | IV | / | Progestinic therapy | / | / |
| 5 | 43 | 97 Kg (30) | IV | Systemic hypertension, Lichen sclerosus | Spontaneous cycle | Unknown, previous hysterectomy | ACE inhibitors |
| 6 | 33 | 79 Kg (26.7) | IV | / | Spontaneous cycle | Ovulatory phase | / |
| 7 | 39 | 63 Kg (20.8) | III | Anxious-depressive disorders | Estroprogestinic therapy | / | / |
| 8 | 28 | 79 Kg (25.5) | IV | / | Spontaneous cycle | Luteal Phase | / |
| 9 | 46 | 66 Kg (24.2) | II | Systemic hypertension, hypothyroidism (Hashimoto disease) | Progestinic therapy | / | ACE inhibitors, Levothyroxine |
| 10 | 40 | 74 Kg (28.9) | III | Systemic hypertension | Gonadotrophin-releasing hormone analogue | / | ACE inhibitors |
| 11 | 41 | 63 Kg (19.4) | II | / | Spontaneous cycle | Follicular Phase | / |
Note *The revised American Society for Reproductive Medicine score is currently the best-known classification of endometriosis and is the one most widely used throughout the world
Abbreviations BMI, body mass index; ACE, angiotensin-converting enzyme